Chemical Structure : Codrituzumab
CAS No.: 1365267-33-9
货号: PC-Ab1037Not For Human Use, Lab Use Only.
Codrituzumab is a humanized monoclonal antibody targeted at glypican-3 (GPC3), which is a member of the glypican family. Codrituzumab binds to glypican-3 (GPC3). Glypican-3 (GPC3) is highly expressed in hepatocellular carcinoma (HCC). Codrituzumab triggers FcγRIIIa-mediated (CD16-mediated) antibody-dependent cell cytotoxicity (ADCC) and/or antibody-dependent cell phagocytosis..
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥3580 | In stock | |
| 5 mg | ¥7580 | In stock | |
| 10 mg | ¥12800 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Codrituzumab is a humanized monoclonal antibody targeted at glypican-3 (GPC3), which is a member of the glypican family. Codrituzumab binds to glypican-3 (GPC3). Glypican-3 (GPC3) is highly expressed in hepatocellular carcinoma (HCC). Codrituzumab triggers FcγRIIIa-mediated (CD16-mediated) antibody-dependent cell cytotoxicity (ADCC) and/or antibody-dependent cell phagocytosis.
| 分子量 | ||
| 分子式 | Human IgG1-Kappa | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             PBS, pH 7.0 Contains no stabilizers or preservatives  | 
                    |
| Chemical Name/SMILES | 
                             Codrituzumab; 1365267-33-9; GC33; RG 7686; RO 5137382; Glypican-3; GPC3  | 
                    |
1. 1, Bell MM, et al. Molecules. 2020 Dec 22;26(1):4. 2, Guo T, et al. J Cancer. 2019 Aug 19;10(19):4671-4678. 3, Onyeisi JOS, et al. Cancer Biol Ther. 2020 Dec 1;21(12):1087-1094. 4, Nakamura M, et al. Br J Clin Pharmacol. 2018 May;84(5):944-951.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright